COVID-19 in cancer patients: managing a pandemic within a pandemic.
Vol. 2 No. 12 (2020), Editorial
Vol. 2 No. 12 (2020)

COVID-19 in cancer patients: managing a pandemic within a pandemic.

Editorial
https://doi.org/10.36557/2674-8169.2020v2n12p01-06
Published 2020-11-29
Karina Figieira
Specialized Dentistry Group (GOE): Macapá, Amapá, BR
https://orcid.org/0000-0003-2828-4474
PDF (Português (Brasil))

Keywords

Covid 19, Sars-Cov-2, Cancer, Oncology, Pandemic, Coronavirus.

How to Cite

Figieira, K. (2020). COVID-19 in cancer patients: managing a pandemic within a pandemic. Brazilian Journal of Implantology and Health Sciences, 2(12), 01–06. https://doi.org/10.36557/2674-8169.2020v2n12p01-06
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Abstract

The 2019 coronavirus disease pandemic (COVID-19) has disrupted health care worldwide. Cancer patients appear to be particularly susceptible to the morbidity and mortality of this new disease. No specific therapy for COVID-19 currently appears to offer a survival benefit for this patient population. In addition, the global effects on routine cancer treatment are likely to be felt only in the coming decades.

https://doi.org/10.36557/2674-8169.2020v2n12p01-06
PDF (Português (Brasil))

References

Chen, N. et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395, 507–513 (2020).

Guan, W. J. et al. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 382, 1708–1720 (2020).

The WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group. Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis. JAMA 324, 1330–1341 (2020).

Garassino, M. C. et al. COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study. Lancet Oncol. 21, 914–922 (2020).

Kuderer, N. M. et al. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet 395, 1907–1918 (2020).

Robilotti, E. V. et al. Determinants of COVID-19 disease severity in patients with cancer. Nat. Med. 26, 1218–1223 (2020).

Tian, J. et al. Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study. Lancet Oncol. 21, 893–903 (2020).

Mehta, V. et al. Case fatality rate of cancer patients with COVID-19 in a New York hospital system. Cancer Discov. 10, 935–941 (2020).

Lee, L. Y. W. et al. COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study. Lancet Oncol. 21, 1309–1316 (2020).

Sharpless, N. E. COVID-19 and cancer. Science 368, 1290 (2020).

Paraguassu, Eber Coelho, et al. "Coronavirus and COVID-19: The latest news and views from the scientific community about the new coronavirus and COVID-19." Brazilian Journal of Implantology and Health Sciences 2.3 (2020): 96-109.

Paraguassu, Eber Coelho. "COVID-19, a relação direta entre o capital, solidariedade e as vidas." Brazilian Journal of Implantology and Health Sciences 2.3 (2020): 01-04.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2020 Karina Figueira